BIO-TECHNE Corp (TECH) Share buybacks
- Total buybacks · last 12 months (USD): Value $41.67M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $41.67M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 41.67M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $41.67M | (m) | (m) |
| 2026-03-31 | $100.08M | (m) | (m) |
| 2025-12-31 | $200.13M | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) |
| 2025-06-30 | $275.73M | (m) | (m) |
| 2025-03-31 | $175.67M | (m) | (m) |
| 2024-12-31 | $75.63M | (m) | (m) |
| 2024-06-30 | $80.04M | (m) | (m) |
| 2024-03-31 | $80.04M | (m) | (m) |
| 2023-12-31 | $80.04M | (m) | (m) |
| 2023-06-30 | $19.56M | (m) | (m) |
| 2023-03-31 | $78.38M | (m) | (m) |
| 2022-12-31 | $139.22M | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) |
| 2022-06-30 | $160.95M | (m) | (m) |
| 2022-03-31 | $102.13M | (m) | (m) |
| 2021-12-31 | $84.47M | (m) | (m) |
| 2021-06-30 | $43.18M | (m) | (m) |
| 2021-03-31 | $43.18M | (m) | (m) |
| 2020-12-31 | $50.11M | (m) | (m) |
| 2020-06-30 | $50.11M | (m) | (m) |
| 2020-03-31 | $50.11M | (m) | (m) |
| 2019-12-31 | $1.00K | (m) | (m) |
| 2019-06-30 | $15.40M | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | (m) | (m) |
| 2015-06-30 | $0.00 | (m) | (m) |
| 2014-06-30 | $0.00 | (m) | (m) |
| 2013-06-30 | $1.82M | (m) | (m) |
| 2013-03-31 | $2.31M | (m) | (m) |
| 2012-12-31 | $5.85M | (m) | (m) |
| 2012-09-30 | $12.92M | (m) | (m) |
| 2012-06-30 | $23.60M | (m) | (m) |
| 2012-03-31 | $21.28M | (m) | (m) |
| 2011-12-31 | $17.75M | (m) | (m) |
| 2011-09-30 | $10.68M | (m) | (m) |
| 2011-06-30 | $1.94M | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | $14.97M | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) |
| 2009-06-30 | $90.63M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |